Roebi de Bruijn

1.5k citations
8 papers · 199 indexed · h-index 6
Topics
Cancer Cells and Metastasis (4 papers)CRISPR and Genetic Engineering (2 papers)BRCA gene mutations in cancer (2 papers)

In The Last Decade

Roebi de Bruijn

8 papers receiving 199 citations

Peers

Roebi de Bruijn
Comparison fields: 5 of 38
  • Oncology 109
  • Molecular Biology 101
  • Cancer Research 59
  • Genetics 39
  • Pulmonary and Respiratory Medicine 35
Replace Alizée Vercauteren Drubbel with:
Alizée Vercauteren Drubbel Belgium
Venu Thatikonda Austria
Bjørn Siteur Netherlands
Séverine Esteyriès France
E.M.S.F. Ribeiro Brazil
Tomáš Brychta Czechia
Sabrina Germoni Italy
Timothy Blake Palculict United States
Ulrike Kostezka Germany
Antonella F. M. Dost United States
Roebi de Bruijn relative to Alizée Vercauteren Drubbel Belgium Alizée Vercauteren Drubbel's profile →
Citations per field
00.5×
Alizée Vercauteren Drubbel · 1×
Citations per year

Countries citing papers authored by Roebi de Bruijn

Since Specialization
Citations

This map shows the geographic impact of Roebi de Bruijn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roebi de Bruijn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roebi de Bruijn more than expected).

Fields of papers citing papers by Roebi de Bruijn

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roebi de Bruijn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roebi de Bruijn. The network helps show where Roebi de Bruijn may publish in the future.

Co-authorship network of co-authors of Roebi de Bruijn

This figure shows the co-authorship network connecting the top 25 collaborators of Roebi de Bruijn. A scholar is included among the top collaborators of Roebi de Bruijn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roebi de Bruijn. Roebi de Bruijn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
#WorkIndexed citations
1 63
2 12
3 20
4 8
5 54
6 3
7 2
8 37

About Roebi de Bruijn

Roebi de Bruijn is a scholar working on Oncology, Dermatology and Genetics, having authored 8 papers that have together received 199 indexed citations. Recurring topics across this work include Cancer Cells and Metastasis (4 papers), CRISPR and Genetic Engineering (2 papers) and BRCA gene mutations in cancer (2 papers). The work is most often cited by research in Oncology (109 citations), Cancer Research (59 citations) and Molecular Biology (101 citations). Roebi de Bruijn has collaborated with scholars based in Netherlands, Australia and United States. Frequent co-authors include Jos Jonkers, Eline van der Burg, Anne Paulien Drenth, Ivo J. Huijbers, Chiara Svetlana Brambillasca, Wilbert Zwart, Lodewyk F.A. Wessels, Colin E.J. Pritchard, Linda Henneman and Colinda L. G. J. Scheele. Their work appears in journals such as Nature Communications, Genes & Development and Clinical Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026